samedan logo

 
 
spacer
home > ebr > autumn 2001 > amyloid - those deadly fibrils
PUBLICATIONS
European Biopharmaceutical Review

Amyloid - Those Deadly Fibrils

<p align="justify" class="feature">The term 'amyloid' was introduced in scientific literature in the mid-19th Century to describe macroscopic abnormalities in organs and tissues of patients afflicted with a variety of clinical syndromes. It took almost a century to realise that these amyloid deposits consisted of fibrillar ultrastructures when examined by electron microscopy (see Figure 1).
Subsequently, numerous studies followed which confirmed that deposits of diverse origin show a similar, fibrillar submicroscopic structure consisting of bundles of straight and rigid fibrils. Several amyloid disorders have since been discovered. Although diverse in etiology and pathogenesis, they all demonstrate this accumulation of large fibrillary protein aggregates which interfere with specificorgan functions.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr Francine Gervais, Vice-President of Research & Development at Neurochem Inc.

As Vice-President of Research and Development, Dr Francine Gervais oversees Neurochem's R&D programme, bringing compounds from discovery through to drug development. Francine came to Neurochem with 15 years' experience in amyloid-related research as an Associate Professor at McGill University. She has been involved in determining the mechanisms responsible for the resistance or susceptibility to disease, including amyloidosis, bacterial and viral infections. Over the years, she has interacted with internationally-renowned research groups on the study of the genetic control of the host response to inflammatory and infectious diseases. Francine holds a PhD in Microbiology and Immunology from the University of Montréal. She began her career with Neurochem as a Consultant, and then joined the company on a full-time basis in June 1997.

spacer
Dr Francine Gervais
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Yusen Logistics expands its healthcare offering with a new unique smart pharma hub in Gembloux

Investments in pharmaceutical and healthcare logistics continue Opening of a new sustainable and state-of-the-art healthcare warehouse in Gembloux by the end of Q1 2024 GSK consolidates its incoming material storages and vaccine distribution for Belgium and worldwide and contributes once again in strengthening the biopharmaceutical ecosystem in Belgium
More info >>

White Papers

A Rules Based Approach to Labelling and Artwork Management

Kallik

Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement